- Home
- CRMD vs KRNY Comparison
CRMD vs KRNY Comparison
Compare CRMD & KRNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRMD | KRNY |
|---|---|---|
| Founded | 2006 | 1884 |
| Country | United States | United States |
| Employees | 191 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 695.9M | 526.7M |
| IPO Year | 2009 | 2014 |
Fundamental Metrics
Financial Performance| Metric | CRMD | KRNY |
|---|---|---|
| Price | $8.77 | $9.38 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 2 |
| Target Price | ★ $14.83 | $9.25 |
| AVG Volume (30 Days) | ★ 1.5M | 710.0K |
| Earning Date | 05-11-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 5.45% |
| EPS Growth | ★ 780.00 | 130.22 |
| EPS | 0.43 | ★ 0.46 |
| Revenue | ★ $311,709,000.00 | $2,580,000.00 |
| Revenue This Year | $0.30 | $3.89 |
| Revenue Next Year | N/A | $17.52 |
| P/E Ratio | ★ $20.44 | $20.46 |
| Revenue Growth | ★ 617.03 | 36.00 |
| 52 Week Low | $6.13 | $5.76 |
| 52 Week High | $14.96 | $9.66 |
Technical Indicators
Market Signals| Indicator | CRMD | KRNY |
|---|---|---|
| Relative Strength Index (RSI) | 58.94 | 69.10 |
| Support Level | $8.09 | $7.36 |
| Resistance Level | $9.03 | N/A |
| Average True Range (ATR) | 0.39 | 0.24 |
| MACD | 0.02 | 0.05 |
| Stochastic Oscillator | 84.34 | 81.02 |
Price Performance
Historical ComparisonAbout CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
About KRNY Kearny Financial Corp
Kearny Financial Corp is a federally-chartered stock savings bank. The bank is engaged in the business of attracting deposits from the general public in New Jersey and New York, and using these deposits, together with other funds, to originate or purchase loans for its portfolios and invest in securities. The bank's loan portfolio is chiefly comprised of loans collateralized by commercial and residential real estate. The bank's primary source of income is net interest income.